|
|
SFX by Ex Libris Inc. |
Contains information about title and source of a journal
Naslov: |
Relationship of dose of background angiotensin-converting enzyme inhibitor to the benefits of candesartan in the Candesartan in heart failure : Assessment of Reduction in Mortality and morbidity (CHARM)-Added trial |
Vir: |
|
|
|
List of services to meet your request
Contains list of services for current record
|
|
|
© 2024 SFX by Ex Libris Inc. | Cookie Policy
CrossRef Omogočeno
|